Cargando…

Development of a patient‐reported experience measure for chronic inflammatory skin diseases

BACKGROUND: Patient involvement and high‐quality patient‐provider interactions are critical factors for quality of care in chronic inflammatory skin diseases. Also, assessing the patient's perspective contributes to optimizing care delivery and patient's experience. Until today, no user‐fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Steen, E., Ramaekers, D., Horlait, M., Gutermuth, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303960/
https://www.ncbi.nlm.nih.gov/pubmed/35122348
http://dx.doi.org/10.1111/jdv.17982
_version_ 1784751993995132928
author Van den Steen, E.
Ramaekers, D.
Horlait, M.
Gutermuth, J.
author_facet Van den Steen, E.
Ramaekers, D.
Horlait, M.
Gutermuth, J.
author_sort Van den Steen, E.
collection PubMed
description BACKGROUND: Patient involvement and high‐quality patient‐provider interactions are critical factors for quality of care in chronic inflammatory skin diseases. Also, assessing the patient's perspective contributes to optimizing care delivery and patient's experience. Until today, no user‐friendly tools to measure patient experiences exist within immunodermatology. OBJECTIVES: The aim of this study was to identify the relevant items for patient's experience in immunodermatology and develop a concise questionnaire to assess patient's experience in routine clinical care. METHODS: Potential relevant items for measuring patient's perspective of immunodermatology care were identified by a literature search. From this longlist, a shortlist from patient's perspective was distilled by semi‐structured interviews with a diverse patient group. This list was reduced to final items using a modified Delphi method in a multi‐stakeholder focus group. For each item, one question was formulated to generate the Patient‐Reported Experience Measure (PREM) questionnaire. A first internal validation was achieved by an email round. RESULTS: Forty longlist items were categorized into five domains (access to care, patient centeredness, access to information, care process and satisfaction). During interview rounds, 19 shortlist items were selected if mentioned by ≥40% of interviewees. Via the focus group, the most important items were chosen by participant consensus. For each item, a question was formulated. The final PREM covers 11 items (plus 2 in case of a first consult). The first internal validation showed that the tool is clear, understandable and has an ideal length. CONCLUSION: This short user‐friendly PREM can be used in scientific and routine settings to improve care for patients who suffer from chronic inflammatory skin diseases.
format Online
Article
Text
id pubmed-9303960
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93039602022-07-28 Development of a patient‐reported experience measure for chronic inflammatory skin diseases Van den Steen, E. Ramaekers, D. Horlait, M. Gutermuth, J. J Eur Acad Dermatol Venereol Quality of Life BACKGROUND: Patient involvement and high‐quality patient‐provider interactions are critical factors for quality of care in chronic inflammatory skin diseases. Also, assessing the patient's perspective contributes to optimizing care delivery and patient's experience. Until today, no user‐friendly tools to measure patient experiences exist within immunodermatology. OBJECTIVES: The aim of this study was to identify the relevant items for patient's experience in immunodermatology and develop a concise questionnaire to assess patient's experience in routine clinical care. METHODS: Potential relevant items for measuring patient's perspective of immunodermatology care were identified by a literature search. From this longlist, a shortlist from patient's perspective was distilled by semi‐structured interviews with a diverse patient group. This list was reduced to final items using a modified Delphi method in a multi‐stakeholder focus group. For each item, one question was formulated to generate the Patient‐Reported Experience Measure (PREM) questionnaire. A first internal validation was achieved by an email round. RESULTS: Forty longlist items were categorized into five domains (access to care, patient centeredness, access to information, care process and satisfaction). During interview rounds, 19 shortlist items were selected if mentioned by ≥40% of interviewees. Via the focus group, the most important items were chosen by participant consensus. For each item, a question was formulated. The final PREM covers 11 items (plus 2 in case of a first consult). The first internal validation showed that the tool is clear, understandable and has an ideal length. CONCLUSION: This short user‐friendly PREM can be used in scientific and routine settings to improve care for patients who suffer from chronic inflammatory skin diseases. John Wiley and Sons Inc. 2022-02-25 2022-06 /pmc/articles/PMC9303960/ /pubmed/35122348 http://dx.doi.org/10.1111/jdv.17982 Text en © 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Quality of Life
Van den Steen, E.
Ramaekers, D.
Horlait, M.
Gutermuth, J.
Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title_full Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title_fullStr Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title_full_unstemmed Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title_short Development of a patient‐reported experience measure for chronic inflammatory skin diseases
title_sort development of a patient‐reported experience measure for chronic inflammatory skin diseases
topic Quality of Life
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303960/
https://www.ncbi.nlm.nih.gov/pubmed/35122348
http://dx.doi.org/10.1111/jdv.17982
work_keys_str_mv AT vandensteene developmentofapatientreportedexperiencemeasureforchronicinflammatoryskindiseases
AT ramaekersd developmentofapatientreportedexperiencemeasureforchronicinflammatoryskindiseases
AT horlaitm developmentofapatientreportedexperiencemeasureforchronicinflammatoryskindiseases
AT gutermuthj developmentofapatientreportedexperiencemeasureforchronicinflammatoryskindiseases